Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Arthritis Research & Therapy|June 15, 2016
Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profileDaniël van der Velden, H Maxime Lagraauw, Anouk Wezel, et al.
Antiviral Therapy|November 21, 2007
Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis BDave Sprengers, Jeroen N Stoop, Rekha S Binda, et al.
Hepatology (Baltimore, Md.)|March 26, 2005
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infectionJeroen N Stoop, Renate G van der Molen, Carla C Baan, et al.
Clinical Immunology (Orlando, Fla.)|October 1, 2008
Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patientsJeroen N Stoop, Mark A A Claassen, Andrea M Woltman, et al.
Arthritis Research & Therapy|August 21, 2015
Abatacept decreases disease activity in a absence of CD4(+) T cells in a collagen-induced arthritis modelDiahann T S L Jansen, Hanane el Bannoudi, Ramon Arens, et al.
Blood|August 18, 2010
Low-strength T-cell activation promotes Th17 responsesHarriet A Purvis, Jeroen N Stoop, Jelena Mann, et al.
NPJ Vaccines|January 30, 2021
Durable natural killer cell responses after heterologous two-dose Ebola vaccinationHelen R Wagstaffe, Giada Susannini, Rodolphe Thiébaut, et al.
The Journal of Clinical Investigation|April 22, 2020
Ebola virus glycoprotein stimulates IL-18-dependent natural killer cell responsesHelen R Wagstaffe, Elizabeth A Clutterbuck, Viki Bockstal, et al.
The Journal of Infectious Diseases|December 11, 2019
Antibody-Dependent Natural Killer Cell Activation After Ebola VaccinationHelen R Wagstaffe, Elizabeth A Clutterbuck, Viki Bockstal, et al.
Vaccines|February 26, 2026
Immunogenicity and Safety of the ExPEC9V <i>Escherichia coli</i> Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 StudyIsabel Leroux-Roels, Tracey A Day, Sofie Deleu, et al.
Pageof 3